SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

Share Price is delayed by 15 minutes
Get Live Data
14.27    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £61.40m
CLLN Live PriceLast checked at - London Stock Exchange

Intraday Carillion Plc Share Chart

Directorate Change

4 Oct 2011 07:00

RNS Number : 4747P
Carillion PLC
04 October 2011
 

 

Carillion plc

 

Board appointments

 

Andrew Dougal has been appointed as a Non-Executive Director of Carillion plc with immediate effect and will also serve as Chairman of the Audit Committee and a member of both the Remuneration and Nominations Committees.

 

Andrew, aged 60, is a Chartered Accountant, and has held a number of senior executive positions, including Chief Executive of Hanson plc, the international building materials company after its demerger from Hanson, the international diversified industrial group, where he was Finance Director. Since his retirement from Hanson plc in 2002, he has served as a Non-Executive Director of a number of UK public companies, including Premier Farnell plc and Creston plc currently, and formerly of Taylor Wimpey plc, Taylor Woodrow plc (until its merger with George Wimpey plc), and BPB plc. He has served as a member of the Audit Committee on all of these companies and Audit Chairman of Taylor Wimpey, Taylor Woodrow and Creston.

 

David Maloney is stepping down from the Board, having served as a Non-Executive Director and as Chairman of the Audit Committee since joining the Board in 2005.

 

Commenting, Carillion Chairman Philip Rogerson said: "David Maloney has made a substantial contribution to Carillion's development and success and leaves the Board with our grateful thanks and best wishes for the future.

"We are delighted that Andrew Dougal has joined the Board, where his considerable experience as an international business leader will enable him to make a valuable contribution to the future development of Carillion".

 

There are no additional disclosures in respect of paragraph 9.6.13 (1) to (6) of the FSA Listing Rules.

 

The Board has also noted the publication of the Davies Review on Women on Boards in February 2011 and the subsequent consultation being undertaken by the Financial Reporting Council in relation to potential changes to the UK Corporate Governance Code. Carillion recognises the importance of gender diversity throughout the Group. Currently, one of our eight Board members is female. The Board aims to have a broad range of skills, backgrounds and experience. While we will continue to follow a policy of ensuring that we appoint the best people for the relevant roles, we recognise the benefits of greater diversity and will continue to take account of this when considering any particular appointment.

 

 

 

Richard Tapp

Company Secretary

4 October 2011

 

Tel: 01902 422431

 

END

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUOVWRABARRAA
Date   Source Headline
3rd Apr 20187:30 amRNSUpdate re Liquidation of Carillion
19th Mar 20187:00 amRNSFRC investigation
17th Jan 20188:15 amRNSAnnouncement Re. Carillion PLC
15th Jan 20187:45 amRNSSuspension - Carillion PLC
15th Jan 20187:00 amRNSCompulsory liquidation of Carillion
12th Jan 20186:08 pmRNSUpdate on discussions with creditors
12th Jan 20185:08 pmRNSHolding(s) in Company
10th Jan 20185:48 pmRNSHolding(s) in Company
9th Jan 20187:03 amRNSResponse to share price movement
3rd Jan 20184:44 pmRNSHolding(s) in Company
3rd Jan 20187:00 amRNSRegulatory investigation
22nd Dec 20177:00 amRNSUpdate on financial covenant deferral
20th Dec 201710:16 amRNSBlock listing Interim Review
20th Dec 20177:00 amRNSChief Executive Appointment
13th Dec 20177:00 amRNSUpdate on UK healthcare facilities business
11th Dec 20177:58 amRNSHolding(s) in Company
1st Dec 20177:00 amRNSDirectorate Change
23rd Nov 201712:08 pmRNSHolding(s) in Company
22nd Nov 201712:29 pmRNSHolding(s) in Company
21st Nov 20174:11 pmRNSHolding(s) in Company
20th Nov 20177:00 amRNSFramework Award
17th Nov 20177:02 amRNSUpdate
15th Nov 20177:00 amRNSOman - letter of award for contract
6th Nov 20177:00 amRNSContract wins
2nd Nov 20177:00 amRNSDirectorate Change
31st Oct 20177:00 amRNSDisposal
27th Oct 20177:00 amRNSChief Executive Appointment
24th Oct 20177:00 amRNSUpdate on financing, disposals and work winning
12th Oct 201712:43 pmRNSUK Healthcare business
4th Oct 20172:58 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSHalf-year Report
22nd Sep 20171:00 pmRNSHolding(s) in Company
19th Sep 20174:55 pmRNSHolding(s) in Company
11th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:17 pmRNSAnnouncement of 2017 interim results
17th Aug 20174:19 pmRNSHolding(s) in Company
15th Aug 20175:58 pmRNSHolding(s) in Company
11th Aug 20176:20 pmRNSHolding(s) in Company
8th Aug 20173:59 pmRNSHolding(s) in Company
8th Aug 201710:02 amRNSHolding(s) in Company
3rd Aug 20179:02 amRNSHolding(s) in Company
1st Aug 201712:24 pmRNSHolding(s) in Company
31st Jul 20172:57 pmRNSHolding(s) in Company
27th Jul 20176:28 pmRNSHolding(s) in Company
18th Jul 201710:49 amRNSHolding(s) in Company
18th Jul 20177:00 amRNSCarillion JV awarded two further HESTIA contracts
17th Jul 20177:19 amRNSHS2 Contract Award
17th Jul 20177:00 amRNSCarillion appoints EY to support strategic review
14th Jul 201712:20 pmRNSHolding(s) in Company
14th Jul 20177:00 amRNSAppointment of Joint Financial Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.